 |
|
Treatment of Invasive Bladder Cancer by Cisplatin and Radiation in Patients Unsuited for Surgery
William U. Shipley, MD;
George R. Prout, Jr, MD;
Albert B. Einstein, MD;
L. Jean Coombs, PhD;
Zev Wajsman, MD;
Mark S. Soloway, MD;
Leonore Englander, MD;
Bruce A. Barton, PhD;
Mark D. Hafermann, MD
JAMA. 1987;258(7):931-935.
Abstract
| |
Seventy patients with muscle-invading bladder carcinoma (clinical stages T2 to T4) who were not candidates for cystectomy were treated with combined cisplatin and full-dose external-beam radiation on a multi-institutional prospective protocol from 1980 through 1985. Thirty-six patients are alive, all but three without evidence of cancer. The complete response rate is 77% in the 62 patients completing planned irradiation and 70% for all patients. Among the complete responders, 73% are currently maintained, and this group has a significantly higher four-year survival than those not having a complete response and those with recurrence of disease—57% vs 11%. The observed high complete response rates in patients in all stages and the high survival rates suggest irradiation plus cisplatin therapy offers an important therapeutic gain over radiation therapy alone for invasive cancer of the bladder. These results encourage further evaluation of combining cisplatin-based, multidrug chemotherapy with irradiation in patients with locally very-advanced bladder tumors who are not suited for surgery.
(JAMA 1987;258:931-935)
Author Affiliations
From the National Bladder Cancer Group and Massachusetts General Hospital, Boston (Drs Shipley and Prout); Virginia Mason Research Institute, Seattle (Drs Einstein and Hafermann); Maryland Medical Research Institute, Baltimore (Drs Coombs and Barton); University of Florida, Gainesville (Dr Wajsman); Rosewell Park Memorial Institute, Buffalo, NY (Dr Englander); and University of Tennessee, Memphis (Dr Soloway).
Footnotes
Presented at the National Cancer Institute Conference on the Interaction of Radiation and Chemotherapy, Williamsburg, Va, Oct 1, 1986.
Reprint requests to Radiation Medicine Service, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA 02114 (Dr Shipley).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Trimodality Treatment and Selective Organ Preservation for Bladder Cancer
Rodel et al.
JCO 2006;24:5536-5544.
ABSTRACT
| FULL TEXT
Bax to Bcl-2 Ratio and Ki-67 Index are Useful Predictors of Neoadjuvant Chemoradiation Therapy in Bladder Cancer
Matsumoto et al.
Jpn J Clin Oncol 2004;34:124-130.
ABSTRACT
| FULL TEXT
Case 3-2004 - A 57-Year-Old Man with Invasive Transitional-Cell Carcinoma of the Bladder
Kaufman et al.
NEJM 2004;350:394-402.
FULL TEXT
Non-invasive Management of Invasive Bladder Cancer: Lectures by Professor William U. Shipley
Ikeda
Jpn J Clin Oncol 2003;33:592-594.
ABSTRACT
| FULL TEXT
Phase III Study of Concurrent Chemoradiotherapy Versus Radiotherapy Alone for Advanced Nasopharyngeal Carcinoma: Positive Effect on Overall and Progression-Free Survival
Lin et al.
JCO 2003;21:631-637.
ABSTRACT
| FULL TEXT
Preoperative Concurrent Chemoradiotherapy Against Muscle-invasive Bladder Cancer: Results of Partial Cystectomy in Elderly or High-risk Patients
Kageyama et al.
Jpn J Clin Oncol 2000;30:553-556.
ABSTRACT
| FULL TEXT
Randomized Comparison of Fluorouracil Plus Cisplatin Versus Hydroxyurea as an Adjunct to Radiation Therapy in Stage IIB-IVA Carcinoma of the Cervix With Negative Para-Aortic Lymph Nodes: A Gynecologic Oncology Group and Southwest Oncology Group Study
Whitney et al.
JCO 1999;17:1339-1339.
ABSTRACT
| FULL TEXT
Selective Bladder Preservation by Combination Treatment of Invasive Bladder Cancer
Kaufman et al.
NEJM 1993;329:1377-1382.
ABSTRACT
| FULL TEXT
New Approaches to the Treatment of Bladder Cancer
Scher
NEJM 1993;329:1420-1421.
FULL TEXT
ALTERNATIVE TO SURGERY FOR ADVANCED BLADDER CANCER
JWatch General 1987;1987:2-2.
FULL TEXT
|
